Articles avec #in english tag

Publié le 2 Avril 2015

Link to the press release (in French).

Two volontary standards are now available to all manufacturers, suppliers, testing laboratories and distributors who will take the responsibility to comply. They are designed to reassure users, encourage good products and support the development of this market worth 400 million euros in France.
A third voluntary standard will be finalized in the summer of 2015 it will focus on the characterization of emissions. It is important to note that the first two French standards will form the basis of European standards projects. France is chairing this work within the European Committee for Standardization (CEN); a first working meeting is scheduled for June 2015.

Manufacturers are free to self-declare complying to the standards (without external control). The manufacturer is then liable, and should provide compliance if requested by any authority. In case of misuse of the AFNOR standard, the Consumer Code punishes this type of deceptive trade practice from 37 up to 500 euros for the individual and 187 500 euros for the corporation.

Professionals can appeal to an independent body to verify compliance with the criteria of the standard and attest, through certification.

Key recommendations of both voluntary standards:

The standard for electronic cigarettes - XP D90-300-1

  • Overheating of the power source or the vaporiser. This is a risk which is prevented by technical security devices and a product information leaflet.
  • Cutting, injuring or exploding risks should be avoided.
  • The coatings used should not release allergenic or toxic substances, or cause burns.
  • Electronic cigarettes must withstand shock, drop test protocol at 1.50 meter high is recommended.
  • Chemical hazards should be limited, metals constituting the resistance of the atomizer should not contain mercury.
  • Two icons are created to indicate the diameter of the electronic cigarette filler hole and the diameter of the tip of the dropper bottle of e-liquid, to avoid use with fine hole electronic cigarette.
AFNOR publishes first world standards for electronic cigarettes and e-liquids

The standard for e-liquids XP D90-300-2, with or without nicotine

The requirements of the standard are very strong on the ingredients to use and not to use.

The safety of the bottle:

  • A childproof cap, and a cap dropper (or cap pipette)
  • Ban all materials that can release molecules that could pose a risk to human health, bisphenol A type for example.

The quality of the ingredients used:

  • Pharmaceutical grade or greater when these qualities exist, for instance propylene glycol, glycerol, nicotine, water (> 90% of e-liquid ingredients)
  • Food grade for alcohol and flavoring mixtures.

The list of prohibited ingredients:

  • Carcinogenic, mutagenic or toxic to reproduction 1 and 2 or respiratory 1 STOT; vegetable and mineral oils; sugars and sweeteners; preservatives that may release formaldehyde, stimulants and drugs, etc.

Label and information sheet:

  • The composition, the deadline for optimal use, safety instructions, population at risk, etc.

Nicotine dosage, reliable information:

  • Labelled constituants may vary by plus or minus 5%. (Ex Nicotine 20 mg / ml).
  • VG / PG ratio (glycerol / propylene glycol) is indicated in weight/weight ratio (eg VG/PG: 25/75).
  • The standard propose examples of methods for the determination of nicotine and some undesirable compounds.

Clear information on ingredients:

  • The ingredients are listed in descending order.
  • Notification for the presence of alcohol > 1.2 ° and food allergens.

A comprehensive information leaflet:

  • Instructions for use, handling, storage, action in case of ingestion or skin contact, information for specific risk groups.
  • Option: available in 2 clicks on the Internet from the address stated on the bottle.

Voir les commentaires

Publié le 1 Avril 2014

Results of ETINCEL-OFDT survey on electronic cigarettes

Prevalence, purchase behaviour, usage, and motivation of e-cigarette users

(Original publication in French is available from OFDT website)

(Scroll down for a PDF version of this translation)


OFDT - Observatoire Français des Drogues et des Toxicomanies [French Monitoring Centre for Drugs and Drug Addiction]
Note n°2014-01: results from ETINCEL-OFDT survey (November 2013)
Saint-Denis, France, 12/02/2014

Aurélie Lermenier and Christophe Palle (OFDT - «Indicators» Unit)
Design and follow-up of the survey : Marie-Line Tovar («General Population Surveys» Unit) & Aurélie Lermenier

English translation by Jacques Le Houezec, translation notes are indicated within brackets [ ]


Presentation of the survey

While electronic cigarettes appear as a growing phenomenon in France over the last two years, data on prevalence and usage remain fragmentary and difficult to interpret due to the lack of information on the methodologies used. Being deeply involved in issues related to tobacco, for the last ten years the OFDT has produced monthly statistical reports and launched every year a detailed summary review. However, it has become increasingly difficult to interpret trends in the tobacco market without taking into account electronic cigarettes. This is why, at the end of 2013, OFDT decided to conduct a survey focusing on this product, with the aim to provide the government and professionals, within a short time frame, the first reliable estimate of this phenomenon1, in order to measure its impact on tobacco for the 2013 annual report.

The ETINCEL-OFDT survey (telephone survey for information on electronic cigarettes) was conducted between 12 and 18 November 2013 among a representative sample of 2,052 individuals aged 15 to 75 years, from the metropolitan population (excluding Corsica). A land-line telephone data base (including numbers starting with 01 to 05 [old numbers denoting geographical areas, before introduction of cable and DSL connections] and 09 [non-geographical numbers, after introduction of cable and DSL], stratified by region and urban category) was randomly generated. The sample of individuals from this data base, interviewed by telephone during one week, was established by the method of quota sampling according to sex, age group, and occupational category. The results were calibrated to the latest data from the INSEE (Institut National de la Statistique et des Études Économiques [French National Institute for Statistics and Economic Studies]).

The questionnaire consisted of 17 questions (see Annex 1). It addresses the issues of awareness of electronic cigarettes, frequency of use, purchase behaviour of electronic cigarettes and e-liquids or refills, user motivations, etc. Questions about tobacco use were also asked to the respondents in order to know the smoking status (e.g. current or ex-smoker) of electronic cigarette users and measure the potential impact on smoking prevalence.

This paper presents the main results of the ETINCEL-OFDT survey and puts them in perspective with other studies conducted in France.

1 Other works and initiatives are under-way to better document the subject: the INPES survey, a regular monitoring and behavioural profile of users of the electronic cigarette by the polling organization IPSOS, a study commissioned by the Ministry of Health at the National Laboratory of Metrology and Testing (including an Internet user survey), and a working group including the Independent Association of E-cigarettes Users (AIDUCE), the E-cigarette Trade Association (ex-CACE, now FIVAPE), the French Office for the Prevention of Tobacco Smoking (OFT), and the National Consumer Institute (INC), with the aim of improving information on products.


A large majority of French people are aware of electronic cigarettes

In November 2013, almost nine out of ten French people (88% [86.8 to 89.6])2 stated that they were aware, at least by name, of electronic cigarettes. In March 2012, the Eurobarometer on tobacco3 indicated that electronic cigarettes awareness in France was already significant, but three points below the European average of 66%. Awareness of this product was greater among young people aged 15 to 24 years (93%) and among managers and higher intellectual professions (93%) and was slightly lower among 65-75 years (83%), and therefore among the retired (85%). Awareness among smokers, who are the target audience for electronic cigarette marketing campaigns (presenting it more or less openly as a means of smoking cessation), was higher than in people who never or virtually never smoked (93% vs. 85%).

2 Figures in brackets indicate the 95% confidence interval.

3 Survey conducted between February 25 and March 11, 2012 in the 27 Member States of the European Union (EU) on user behaviour and purchase of tobacco, with three questions on the electronic cigarette. In total, more than 26,700 individuals aged 15 years and older, selected by a random method, were interviewed face -to-face in all EU countries. In France, it was about 1,059 individuals (see TNS Opinion & Social, Attitudes of European Towards tobacco , Special Eurobarometer 385, Brussels , European Commission, 2012 , 167 p.).


What is an electronic cigarette?

Developed in China in the mid-2000s, the electronic cigarette, also known as the e-cigarette mimics the feeling of a classic tobacco cigarette. There are two types : disposable (looks like a real cigarette) and rechargeable (AC or USB cable ; it then rather looks as a large pen). Rechargeable electronic cigarettes (the majority of the French market) consists of a battery, a clearomiser that contain a resistance and the e-liquid, and a tip that allow to inhale the vapour generated at the clearomiser. By pressing a button, the battery supplies the resistance with power which heats the e-liquid soaked by the wick of the clearomiser and turns it into vapour, which is inhaled by the user. The e-liquid is made of propylene glycol and/or vegetable glycerin, various flavours (tobacco, mint, apples, etc.), a small proportion of alcohol and/or purified water, and may contain or not nicotine at different concentrations.


Already one in five French people used it at least once

At the end of 2013, 18% [16.7-20.1] of people surveyed reported having used at least once an electronic cigarette. This is 2.5 times more than in March 2012, when the rate of experimentation in France was 7 % (identical to that in all countries of the European Union).3

Among those who had not yet tried electronic cigarettes, only a small minority (2.3% [1.6-3.0]) intended to do in the near future. This proportion of potential experimenters was twice as high among manual workers (4.9%), and five times higher among smokers (11.2%).4

4 The over representation of manual workers among potential electronic cigarette experimenters is partly due to the fact they are more likely than average to smoke (33% vs. 27%). Unemployed people, and to a lesser extent, self-employed workers, merchants and business owners are also more likely than average to smoke and more often declare their intention to try electronic cigarettes, but the difference is not significant.


Rather young experimenters, and tobacco users

Men were more likely than women to have ever used electronic cigarettes (22% vs. 15%). The proportion of experimenters decreased as age increased (Figure 1) : nearly a third (31%) of 15-24 years-old had tried them, as opposed to no more than one in five of 35-44 years-old, and one in ten (9%) between 55-64 years-old. For reasons probably more related to age than professional status, retired people were less likely to try these products. Not surprisingly, being a smoker or having smoked in life influences the level of experimentation : half of smokers (51%) report having tried electronic cigarettes as opposed to only 12% in ex-smokers, and 3.5 % among respondents who never or rarely smoked.5 Thus, among the experimenters, three quarters were smokers, one in six was a former smoker and nearly one in ten (9% ) had never smoked or had only tried smoking. Furthermore, although the sample size makes it difficult to draw geographic comparisons, experimentation appears less common in the north (Nord-Pas-de-Calais: 7.9 %) than in the west (23,1% in the area consisting of the regions Brittany, Pays de la Loire, and Poitou-Charentes) and the South west (21,3% in Aquitaine, Limousin, and Midi-Pyrénées).

5 This difference by current or past smoking status is also checked in Britain where a survey of over 12,000 adults was conducted in February 2013 by the Association of Prevention Action on Smoking and Health (ASH ) for the prevalence of use ( cf. ASH , Use of e- cigarettes in Great Britain Among adults and young people (2013) , London, ASH , 2013 , 4 p.).


Electronic cigarette use concerns one in fifteen person in the last month

At the end of 2013, recent use (within the last thirty days and excluding experimentation) of electronic cigarettes concerned 6.0% [5.0-7.0] of French people, or a third of those who tried them.6 Although they were more likely to experiment than older people, 15-24 years-old were proportionately less likely to have used it in the month preceding the survey, followed by 25-34 years-old. It is after the age of 35 that people seemed more likely to "adopt" electronic cigarettes after having tried them (Figure 1): regardless of their age group, more than one experimenter in three reported recent use. It is likely that the trendy effect is playing more in young people experimentation, who would try it more by curiosity, while older users are more likely to use them specifically to reduce or stop tobacco use.

6 In March 2013, a so-called omnibus telephone survey ( on various topics ) Ipsos Observer, with a sample of 950 individuals representative of the adult population ( quota method ) resulted in a proportion of 3.5% of users more or less regular.






Figure 1 : Proportion of experimenters (blue bars), recent use (red bars), and daily use (green bars) of electronic cigarettes, by age group
Source : ETINCEL-OFDT survey (November 2013)


Unlike experimental use, more common in men, there was no gender difference in recent (and daily) use of electronic cigarettes. Apart from the lower proportion of retired people among users in the last month (3.1%), given their age, there was also no significant differences according to their socio-economic category. However, as for experimental use, use in the last month was higher in the West of the country (9.3%), and lower in the North (1.6%), possibly due to an easier access to cheaper tobacco in Belgium and Luxembourg.

All recent users of electronic cigarettes reported current tobacco use, or having used tobacco in their lifetime, but smokers were significantly more likely to use electronic cigarettes than ex-smokers (78% vs. 22%).


Slightly more than 3% of daily users

More than half (54%) of those who used electronic cigarettes in the last month use them daily, or 3.3% [2.5 to 4.1] of French people (Figure 2). As already observed for recent use, the difference between the youngest and the oldest users was confirmed for daily use: among recent users of electronic cigarettes, only 44% of 15-24 years-old used them daily, as opposed to 50-75% of 50-75 years-old. This seems to reinforce the hypothesis that young people would bow to fashion, whereas those being over 50 years-old are more likely engaged in giving up tobacco use or in harm-reduction, as soon as they try them, certainly in relation with being older. When faced with health damages, actual or perceived as very likely, caused by usually long-life (several decades) smoking, older smokers tend to turn to electronic cigarettes to reduce their risks.7

7 According to a British study, electronic cigarettes would deliver half as much formaldehyde (a known carcinogen), 23 times less toluene (a toxin), 130 times less acetaldehyde (suspected carcinogen) and 30-145 times less tobacco specific nitrosamines (highly carcinogenic): Maciej L. Goniewicz "E-cigarettes: a review of Their efficacy and potential for harm reduction."


Figure 2 : Proportion of experimenters, recent users, and daily users of electronic cigarettes in France
Experimental use: 18 %, Use in the last month: 6 %, Daily use: 3.3 %, Exclusive use: 1,3%

Source : ETINCEL-OFDT survey (November 2013)


Many daily users of electronic cigarettes are still using tobacco, since two-thirds of them were dual users (tobacco and electronic cigarettes). However, among them, more than six in ten (62%) used "electronic cigarettes most of the time and tobacco sometimes"; a quarter of them responded the opposite.
Exclusive electronic cigarette users, i.e those who do not currently use tobacco, represented 1.3% [0.8-1.8] of the surveyed sample, and the vast majority (81%) used them daily.


A growing usage since spring 2013

Three quarters (76%) of vapers8 who used electronic cigarettes during the thirty days preceding the survey started using them less than six months ago, that is to say, since April-May 2013, which coincides with a period of extensive media coverage, particularly related to a report on the subject submitted by OFT9 to the Ministry health. Only 13% reported having started to use them more than one year ago.

The vast majority (78%) of those who used electronic cigarettes in the last month owned their own electronic cigarette, while 16% used those belonging to other people (the remainder sharing them with one other user: spouse, friend, etc.). This latter figure may be explained by the desire to test the product and the liquid flavours before making a purchase that represents a certain upfront investment: a minimum spend of 50 Euros for a rechargeable electronic cigarette and a little less than 6 Euros per 10 ml bottle of e-liquid. A lower proportion of vapers aged 15-24 owned their own electronic cigarette (44%), probably because they are often less likely to be regular users, while the proportion rose to 93% among 35-54 years-old.

Nearly a quarter (24%) of recent users reported not knowing the nicotine content of the liquid or refill for the electronic cigarette they used (the majority of these being people who did not own their own). Among those who did know, 11% reported using a 0 mg/ml concentration (no nicotine), highlighting the low proportion of non-nicotine-dependent users, or those who have successfully given up, after a gradual reduction in nicotine dosage. Four in ten vapers choose a medium dosage (between 7 and 12 mg/ml), while the remaining users were equally distributed (24%) between low dosage (between 1 and 6 mg/ml) and high ones (greater than 12 mg/ml).10

8 The most common term for people using electronic cigarettes

9 French Office for the Prevention of Smoking, Report and expert opinion on e-cigarettes, Paris, OFT, 2013, 212 p.

10 Nicotine concentration rarely, if ever, exceed 20 mg/ml in French outlets.


Purchases mainly in speciality shops

The electronic cigarettes market is still poorly organized and regulated,11 and it is shared by many manufacturers and retailers. However, the majority of purchases by those surveyed (58%) were made in speciality shops for this type of product, even though the purchases in tobacconists [a monopoly for tobacco sales in France] was by no means negligible (21% - Figure 3). The Internet is a rather small source of supply: 9% of those surveyed bought their electronic cigarette online. Purchases from pharmacies [a monopoly for drugs in France, where there exist no GSL even for OTC drugs], which are actually prohibited to sale these products,12 or from supermarkets were mentioned, but concerned very few purchasers. Speciality shops were also the source of the majority of purchases of e-liquids and refills: 54% of those surveyed used them, whilst 24% did it in a tobacconist.

No matter where they purchased their electronic cigarette, a very large proportion of users used the same supply channel for purchasing refills. This was especially true for tobacconists (91%) but also for speciality shops (88%): although there is no evidence to establish whether this was in the same place, this figure may well suggest that users are attached to the personal relationship with a vendor who can advise them.

Finally, the market for disposable electronic cigarettes appears to be very small: only 4% of those who had used electronic cigarettes in the last month used these type of products, which are sold mostly for trial purposes, rather than of loyalty. Indeed, they are easy to use, similar to conventional cigarettes and allow to try the product at a low cost. It is likely that with the increase in electronic cigarettes use, disposables have experienced a decline in their market share.

11 A professional organization, the Collective actors of the electronic cigarette (CACE), [now called FIVAPE for Inter-professional Federation for Vaping) was created in January 2013. It includes manufacturers, distributors, retailers, etc. of the electronic cigarette sector, and aims to defend the interests of its members at national and European level, in particular by proposing specific regulations. They also initiated a training center for professionals near Bordeaux. In December 2013, another organization, the National Union of Professional of electronic cigarettes (Synapce) was also created.

12 Electronic cigarettes not being a medical device or a drug and not part of the list of authorized products for sale in pharmacies (Article L.5125-24 of the Code of Public Health), they should not be sold in pharmacies. Despite reminders from the National Agency for Medicines and Health Products (MSNA) and the Council of the College of Pharmacists, many pharmacies continue to sale them (


Figure 3: Distribution of locations where electronic cigarettes are purchased in France
Speciality shop 58%, Tobacconist 21%, The Internet 9%, Pharmacies 5%, Other places 8%

Source : ETINCEL-OFDT survey (November 2013)


Primary motivation : giving up completely

Half (51%) of people surveyed who reported simultaneous use of tobacco and electronic cigarettes spontaneously claimed that their main and ultimate goal was to stop completely the use of both products.13 Among the motivating factors reported, next came, but far behind, the reduction of tobacco consumption but without giving up entirely (11.5%), and then substituting electronic cigarettes for tobacco (8.2%), both of which might relate to a form of harm-reduction. Other users highlighted the decrease in health risks, reduction in tobacco inconveniences, cost, and the ability vape anywhere.

The product is therefore strongly linked to the idea of smoking cessation, and even beyond that to reduce or even to eliminate any nicotine dependence. According to a survey conducted in Great Britain among users of electronic cigarettes,14 the idea of smoking cessation was also the most common: 34% of vapers reported using electronic cigarettes to quit smoking, and 28% "because they had already tried to quit and wanted something to help to stop for good." They were 22% to want to reduce their consumption without giving up completely, and the same proportion to be motivated by the potential savings.15
Among the very small proportion of surveyed people who were former smokers (even occasional ones) and had used electronic cigarettes within the last month (namely 1.2%), most of them (84%) considered they had completely stopped smoking by using them: this represents 1% of the French population. Without presuming the effectiveness of electronic cigarettes for smoking cessation,16 especially as the numbers here are very small, it seems that smokers are convinced of its usefulness for achieving this goal, as an alternative to nicotine replacement therapy and smoking cessation medications. This opinion is also shared by a significant part of the population: as 43% of French people believe that these products are an effective mean to reduce or stop smoking.17

13 This objective was slightly more often cited by users aged 50-75, confirming the hypothesis that older users are more motivated to quitting than the younger ones, however, the difference was not significant.

14 Action on smoking and health (ASH), op. cit.

15 Unlike the question in this survey for which a single response ("primary and long-term objectives") was possible, the British respondents could give multiple answers, so the total exceeds 100%.

16 In September 2013 , The Lancet published the results of a study conducted in New Zealand (University of Auckland) on the efficacy of electronic cigarettes on smoking cessation: this product appeared to be comparable to the nicotine patch in helping smokers to quit over a period of at least six months, however, it was more effective in reducing daily consumption among those who did not quit, and seemed to be more appealing than the patch, particularly in the long-term (see BULLEN C. et al . "Electronic cigarettes for smoking cessation : a randomized controlled trial ," The Lancet , vol 382, 2013 , pp. 1629-1637.

17 Survey conducted by Clopinette, one of the market leaders in electronic cigarettes in France , on 22 and 23 November 2013 among a representative sample of 969 French adults (quota sampling method).



In November 2013, the vast majority of the French population had heard about electronic cigarettes, and between 7.7 to 9.2 million people had tried them, mainly young people and smokers. In the month preceding the survey, 6% of the population were using electronic cigarettes. Between 1.1 and 1.9 million people reported daily use of electronic cigarettes in France: some 67% of tobacco smokers used them mainly to stop or reduce their daily tobacco consumption, and therefore potentially the health risks associated with smoking. Although 9% of those using electronic cigarettes reported having never or rarely smoked tobacco, all the regular vapers were or had been smokers: electronic cigarettes appear therefore, at least for the moment, to rather be a way out of smoking, rather than a "gateway" into smoking.

The exclusive use of electronic cigarettes is fairly limited, but may increase over time, as smokers use these products to reduce their tobacco dependence. The ultimate goal of vapers is focused on complete cessation; with three quarters of regular users having started using electronic cigarettes less than six months before the survey, more time may be needed before effective cessation is confirmed, which at the end of 2013, represents 1% of the French population.

Rechargeable electronic cigarettes represent the vast majority of the market (over 95% of those who had vape in the month) and the purchase of the object itself and the refills are made primarily in speciality shops (over 50 %) and tobacconists (over 20 %).

Further surveys are needed to consolidate these findings and their evolution over time. At the beginning of 2014, the increased media attention and the strong momentum of the electronic cigarette market show no sign of slowing: it is therefore likely that the number of users, going from experimentation to daily use, will continue to rise.




Annex 1. Questionnaire

Survey on behaviour of use and purchase of electronic cigarettes and tobacco


Part I : Electronic Cigarette

Q1 - Have you heard, even if only by name, of electronic cigarettes, also known as “e-cigarettes”, “personal vaporisers” or “vaporette”?

1- Yes

2- No


Q2 - (if yes to Q1) Have you ever tried an electronic cigarette?

1- Yes

2- No


Q3 - (if no to Q2) Do you intend to try an electronic cigarette in the near future?

1- Yes - Go to Q10

2- No - Go to Q10


Q4 - (if yes to Q2) Have you used an electronic cigarette within the last 30 days (apart from for the first time)?

1- Yes

2- No - Go to Q10


Q5 - (if yes to Q4) How often do you use electronic cigarettes?

Interviewer: List responses

1- Every day

2- Several times a week

3- Once a week

4- Two to three times a month

5- Once a month

6- (Don’t know)


Q6 - (if yes to Q4) When did you start using electronic cigarettes?

Interviewer: List responses

1- Within the last 30 days

2- Between 1 and 6 months ago

3- More than 6 months ago, but less than a year ago

4- One year ago or more

5- (Don’t know)


Q6bis - (if yes to Q4) Do you have your own electronic cigarette?

Interviewer: List responses

1- Yes, I have my own

2- No, I share it with someone else

3- No, No, I use other people’s - Go to Q9

4- Other (explain) - Go to Q9


Q7 - ( if yes to Q4) Where did you most recently buy your electronic cigarette?

1- From a shop specialising in electronic cigarettes

2- Online

3- From a tobacconist

4- From a chemist

5- Other (explain)


Q8 - (if yes to Q4) Where did you buy your most recent e-cigarette refill (liquid, cartridge, etc.)?

1- From a shop specialising in electronic cigarettes

2- Online

3- From a tobacconist

4- From a chemist

5- Other (explain)

6- (Not applicable, I use disposable cigarettes)


Q9 - (if yes to Q4) What dose of nicotine do you use in your electronic cigarette?

Interviewer: for zero nicotine, use code 0 and for “don’t know” use code 99



Part II : Tobacco

We are now going to ask you some questions on your tobacco consumption (cigarettes, roll your own tobacco, cigars, cigarillos, pipe, shisha/hookah, etc.) in addition to your use of electronic cigarettes.


Q10 - Do you smoke tobacco, even if only occasionally?

1- Yes

2- No - Go to Q12


Q11 - (if yes to Q10) Did you smoked tobacco within the last 30 days…?

Interviewer: List responses

1- Every day

2- Several times per week

3- Once per week

4- Two to three times in the month

5- Only once in the month

6- (Don’t know)


Q12 - (if no to Q10) Have you ever in your life smoked tobacco regularly or from time to time?

1- Yes, regularly

2- Yes, from time to time

3- (I have only tried it) - Go to Q17

4- (Never) - Go to Q17


Q13 - (if yes to Q12 and yes to Q4) Did you completely stop smoking due to the use of electronic cigarettes ?

1- Yes - Go to Q17

2- No - Go to Q17


Q14 - (if yes to Q10) Where did you last buy your tobacco for your own consumption (pack of cigarettes, roll your own tobacco, cigars, cigarillos, pipe, shisha/hookah, etc.) ?

Interviewer: do not prompt

1- From a tobacconist in France

2- From a tobacconist in a country bordering France (Spain, Andorra, Monaco, Italy, Switzerland, Germany, Luxembourg, Belgium)

3- From a tobacconist in another country

4- From duty-free

5- Online

6- On the street

7- Other

8- (Don’t know)


Part III : Tobacco and electronic cigarette

Q15 - (if yes to Q4 and yes to Q10) Do you currently use…?

Interviewer: List responses

1- Electronic cigarettes most of the time and tobacco sometimes

2- Electronic cigarettes as often as tobacco

3- Tobacco most of the time and electronic cigarettes sometimes

4- (Other)


Q16 - (if yes to Q4 and yes to Q10) In the long term, is your main reason for using electronic cigarettes to…? ONE RESPONSE ONLY

Interviewer: Do not prompt – use codes

1- Stop smoking and vaping completely (tobacco and electronic cigarettes)

2- Reduce my tobacco consumption without stopping smoking tobacco

3- Reduce my tobacco consumption without stopping using electronic cigarettes

4- Substitute electronic cigarettes for tobacco

5- Reduce my spending on tobacco/save money

6- Be able to vape wherever I like (in the office, at home, etc.)

7- Reduce tobacco-related issues (bad breath, yellow teeth, smell of stale smoke, etc.)

8- Reduce the risk of harming my health without stopping smoking tobacco/they are less dangerous for my health

9- No longer be addicted to nicotine/gradually reduce my nicotine dependence using e-cigarettes

10- Other (explain)

11- (Don’t know)



Annex 2. Regulation


At National level

Current French legislation does not consider electronic cigarettes to be a tobacco products, since they do not contain tobacco and do not involve combustion. For this reason, they are not strictly speaking subject to tobacco product regulations, although they are tending towards it. An amendment prohibiting sale to minors was therefore included in the consumer bill (agreement having been reached on this point, this prohibition is set to become law in 2014) and the Ministry of Health wants to ban their use in public places and bars, restaurants etc., despite the fact that no legislative framework has yet been agreed (the Ministry having referred the matter to the Conseil d’État, which has yet to rule). For the moment, only an organisation’s internal regulations can limit their use (as is already the case for some public transport systems, such as RATP, SNCF, Air France, etc.) and the Saint-Lô city council is the only authority to date to have banned use of electronic cigarettes (by administrative order) inside local authority buildings.

Advertising electronic cigarettes is not specifically prohibited, but may fall within the ambit of France’s “Évin” law, which prohibits “any direct or indirect advertising or promotion of tobacco or tobacco products”. Indeed, the hand to mouth behaviour, the vapour released, the possible presence of nicotine, etc. are all so similar to a real cigarette that it is considered that they could possibly encourage smoking. It is this point of law, and more generally, the infringement of the monopoly on tobacco sales that have prompted a French tobacconist to take action for “unfair and illegal competition” against an electronic cigarette retailer located in the vicinity of his business. In December 2013, the Commercial Court of Toulouse found in his favour, relying on Article L.3511-1 of the Code de la Santé Publique [French Public Health Code], which defines tobacco products as “products designed to be smoked […] whether or not they contain tobacco, with the sole exclusion of products designed for medicinal purposes”. The electronic cigarette retailer has appealed this decision, which, if confirmed, could set a precedent and result in the closure of speciality shops in favour of reinstating the tobacconists’ monopoly.

In France, electronic cigarettes are also not considered to be smoking cessation aids or medicinal products, since no manufacturer has claimed as such, which would require them to obtain authorisation to place such products on the market. In the absence of sufficient scientific research on the safety of electronic cigarettes, or on any potentially harmful effects they may have on health, the Agence Française de Sécurité Sanitaire des Produits de Santé (AFSSAPS, which became the Agence Nationale de Sécurité du Médicament et des Produits de Santé, the French National Agency for the Safety of Medicines and Health Products, or ANSM) advised against using them in 2011 (


At European and international levels

Discussions to provide a framework for electronic cigarettes at European level fall within the scope of the review of the Tobacco Products Directive 2001/37/EC, which regulates the manufacture, presentation and sale of these products. In December 2012, the European Commission submitted to the European Council and the European Parliament a proposal for a Directive, which was the subject of numerous debates between the various parties involved throughout 2013. Originally planned for September, the proposal to strengthen legislation on tobacco products was examined by the European Parliament in October 2013 (increase in the size of health warnings, prohibition on flavoured cigarettes (except for menthol, for which an extension is granted), list of authorised additives, etc.). The decision to classify electronic cigarettes as tobacco products or medicinal products having not yet been taken, their status as ordinary consumer goods will therefore be retained.

In mid-December, the 28 Member States of the European Union reached agreement on this future “Tobacco Directive” to control tobacco smoking and to better regulate the electronic cigarette market. Consequently, sales of these products to those under 18 years-old will be prohibited, although countries which deem them to be medicinal products may continue to do so (without obliging others, such as France, to do so), the maximum concentration of nicotine will be set at 20 mg/ml (which is a level rarely, if ever, exceeded in points of sale in France) and the European Commission is to submit a report on the health risks associated with using electronic cigarettes within two years.

This agreement is set to be ratified by the European Parliament and at a plenary meeting of the Member States in February/March 2014, before being definitively adopted. After this, each country will have two years to transpose the Directive into domestic law, which means it will not be in force before 2016.

At international level, the World Health Organisation advises against using electronic cigarettes, as long as there is no scientific evidence that they are safe. Only a few countries have imposed a total ban on this product, among them, Brazil, Argentina and Singapore; in others, such as Switzerland and Canada, only zero-nicotine electronic cigarettes can be marketed.


Download PDF version of this translation here

Voir les commentaires

Publié le 13 Janvier 2014

Publié le 17 Décembre 2013

Une enquête sur les arômes utilisés par les "vapers", publiée par K. Farsalinos

Voici une nouvelle étude publiée par l'équipe de K. Farsalinos. C'est une enquête réalisée chez plus de 4500 participants ayant répondu à un questionnaire sur internet. Les résultats ont été interprétés en fonction du statut tabagique des participants, soit encore fumeurs, soit ayant arrêté de fumer. La grande majorité étaient des ex-fumeurs (91,1%), les fumeurs ayant réduit considérablement leur quantité de tabac fumé, passant en moyenne de 20 à 4 cigarettes par jour. Dans les deux groupes, la durée moyenne du tabagisme était de 22 ans, et l'utilisation d'une e-cig était de 12 mois. En moyenne, tous les utilisateurs utilisaient 3 arômes différents de façon régulière, et les ex-fumeurs passaient plus régulièrement d'un arôme à l'autre au cours de la journée (69,2%) que les fumeurs (58,3%). Les arômes tabac sont les plus utilisés lors de l'initiation (68 à 69%), mais ce sont les arômes de fruits qui l'emportent par la suite. Sur une échelle de 1 (pas important du tout) à 5 (très important), les participants ont indiqué que la variabilité des arômes était un facteur important (score = 4) pour réduire ou arrêter de fumer. La grande majorité des participants ont rapporté qu'une restriction sur le nombre des arômes disponibles rendrait l'utilisation de la e-cig moins agréable et voire ennuyeuse. Et 48,5% que cela accroîtrait leur envie de fumer, et 39,7% que cela leur aurait été moins facile de réduire ou d'arrêter de fumer. De plus, plus le nombre d'arômes utilisés est important, plus les chances d'arrêts sont grandes (p=0,038).

Les auteurs concluent que la diversité des arômes est un facteur important et qu'elle est le résultat d'une demande des utilisateurs pour leur satisfaction à vaper. Cette diversité contribue à la fois au plaisir ressenti et à faciliter la réduction ou l'arrêt du tabac. Ils concluent aussi que compte tenu de la faible utilisation de la e-cig chez les jeunes, une restriction législative sur les arômes pourrait mettre en danger les bénéfices de la vape chez les utilisateurs, sans gain en termes de santé publique chez les jeunes.

L'article en accès libre est ici / open access article here

Voir les commentaires

Publié le 15 Décembre 2013

De bonnes nouvelles pour l'avenir de la e-cig ? Une réunion importante a eu lieu vendredi 13 décembre.

Le lien vers le communiqué de l'AIDUCE (scroll down on AIDUCE website for an English version):

Selon le communiqué de l'AIDUCE:

"Sous l’égide de l’Institut national de la consommation (INC), l’Association indépendante des utilisateurs de cigarette électronique (Aiduce), le Collectif des acteurs de la cigarette électronique (Cace) et L’Office français de prévention du tabagisme (OFT), ont décidé, le 13 décembre à Paris, de s’associer pour améliorer l’information délivrée aux consommateurs et la qualité des produits commercialisés en France.
Surmontant leurs divergences, les délégations sont convenues, lors d’une rencontre à l’INC, de travailler ensemble sur quatre dossiers prioritaire
s :

  • La définition de règles communes d’information (harmonisation de l’étiquetage et des documents d’information à destination des utilisateurs) ;
  • La mise en place d’une marque ou d’un label de qualité pour les produits respectant de strictes exigences de qualité, dans l’attente d’une norme européenne que les participants appellent de leurs vœux ;
  • La mise en place d’un observatoire de la cigarette électronique et des pratiques de vapotage, afin de contribuer à une meilleure connaissance de ce marché ;
  • La formation des vendeurs."

Cela pourra-t-il décider l'Europe à reconsidérer sa position? Nous attendons les décisions de la dernière réunion du trilogue demain, 16 décembre.

Voir les commentaires

Publié le 10 Décembre 2013

Un document secret a encore fuité, c'est le texte qui sera proposé demain à la réunion du trilogue. Désolé pour les non anglophiles, c'est en anglais (mais vous savez qui...peut vous faire une traduction à peu près lisible).

C'est ici, sur le blog de Clive Bates.

Descendez directement au point 7, celui rajouté aujourd'hui.

En résumé, les rechargeables sont toujours interdits, ce qui est inacceptable, sans parler de la limitation de la dose de nicotine et de toute possibilité de parler de e-cigarette ailleurs que dans des publications professionnelles. La seule solution reste de faire enlever de la Directive toute allusion à la e-cigarette, et de proposer une nouvelle législation pour cela. C'est aussi le seul moyen de sauver la Directive tabac qui sinon risque de ne pas être votée (et vous savez à qui ça fera plaisir !!).

Voici le texte en question:

Voir les commentaires

Publié le 2 Décembre 2013

Notre lettre aux députés a été publiée aujourd'hui dans le Financial Times :
Our letter published today in the Financial Ti
mes :

Voir les commentaires

Publié le 1 Décembre 2013

Lettre envoyée à tous les Députés européens, de tous les pays, suite à la fuite d'un document de la Commission européenne (plus de détails, en anglais ici).

Notre lettre a été publiée aujourd'hui dans le Financial Times :
Our letter published today in the Financial Times

Mesdames et Messieurs les Député(e)s européen(ne)s,

Le tabagisme est la première cause de maladie et de décès évitable en Europe: 29% des adultes fument, et 700000 européens en meurt chaque année. Alors que les méthodes d'aides à l'arrêt conventionnelles stagnent et n'ont guère permis d'avancée récemment, la e-cigarette aide de plus en plus de fumeurs à passer à une alternative plus sûre, on estime qu'il y a entre 7 et 12 millions d'utilisateurs européens.

Cependant, ce phénomène pourrait s'arrêter soudainement. La Directive sur les produits du tabac européenne a proposé de réglementer la e-cigarette comme un médicament. La réglementation du médicament impose des coûts importants, défavorisant la e-cigarette par rapport au tabac, et ralentirait considérablement l'innovation. Cela aurait pour conséquence d'éliminer tous les produits actuellement sur le marché. Le Parlement européen s'est opposé à cette réglementation médicale, favorisant une réglementation de produit de consommation courante. La Commission européenne propose maintenant un amendement qui définirait la e-cigarette comme un produit du tabac (ce qu'elle n'est pas) et imposerait l'interdiction de la plupart des arômes (qui représentent une part importante de l'attrait de ce produit pour les fumeurs), une limite de concentration et de contenu total en nicotine, l'interdiction des systèmes rechargeables (qui sont préférés par les utilisateurs), et une interdiction de publicité similaire aux produits du tabac. Ces propositions limiteront considérablement l'attrait de ces produits pour le consommateur.

Une telle réglementation favoriserait la vente des cigarettes conventionnelles de tabac au détriment de la e-cigarette considérablement moins dangereuse. Nous demandons expressément au Parlement européen de s'opposer à cette tentative de réintroduire une réglementation médicale dans son dos.

Veuillez agréer, Mesdames et Messieurs le Député(e)s européen(ne)s, l'expression de notre profond respect.

Jacques Le Houezec, Consultant en Santé publique, Rennes, France
Dr Philippe Presles, Institut Moncey, Paris, France
Dr Gérard Mathern, Saint-Chamond, France
Prof Gerry Stimson, Emeritus Professor, Imperial College London, London, UK
Prof Peter Hajek, Wolfson Institute of Preventive Medicine Barts and Queen Mary University, London, UK
Dr Lynne E. Dawkins, University of East London, UK
Dr Miroslaw Dworniczak, Poznan, Poland
Dr Konstantinos Farsalinos, Onassis Cardiac Surgery Center, Greece and University Hospital Gathuisberg, Belgium
Prof Riccardo Polosa, Director of the Institute for Internal Medicine and Clinical Immunology, University of Catania, Italy.
Dr Michał Kozłowski. eSmoking Institute, Poznan, Poland
Prof Demetrios Kouretas, School of Health Sciences and Vice Rector of University of Thessaly, Greece
Prof Andrzej Sobczak, Medical University of Silesia, Katowice, Poland
Prof Aristides Tsatsakis, University of Crete, Greece

Vous pouvez vous aussi écrire à vos députés, et rejoindre la pétition internationale à :

Voir les commentaires

Publié le 15 Novembre 2013

My presentation at the E-cigarette Summit, London

Here is a link to the transcript of my presentation on nicotine safety at the recent e-cigarette Summit in London (12/11/2013).

All the presentations from the other speakers are also available here:

Ma présentation sur la nicotine, ainsi que les présentations de tous les orateurs sont disponibles (en anglais) à partir des liens ci-dessus.

Voir les commentaires

Publié le 15 Novembre 2013

Vous pouvez aussi rejoindre l'appel des 100 (médecins, professionnels de santé et grand public) ici:

You can now join the call (physicians, health professionals, or public/individual) at:

(click on "je rejoins l'appel")

L'appel des 100 relayé par le Quotidien du médecin :

The French version was published today in Le Parisien (la version française est disponible ici):


Initiated and coordinated by Dr. Philippe Presles

As physicians and health professionals we see patients severely affected by tobacco smoking daily, many of which will die or be disabled despite our daily care. This is the most serious problem of public health in the world. However, we see further expand the use of electronic cigarettes that clearly help many smokers to turn the page of tobacco. But misconceptions have emerged that limit their diffusion, while its potential in terms of public health is real.

It is therefore appropriate to say that :

  • This is the combustion of tobacco that is harmful to health of smokers, not nicotine. It is well established that nicotine replacement therapy is not harmful to health of smokers who want to quit. The same is true for the nicotine in e-cigarettes;

  • The main toxins produced by the combustion of tobacco, present in the smoke, are the carbon monoxide or CO, responsible for myocardial infarction and stroke, carcinogens from tar, and fine particles resulting in chronic obstructive bronchitis. The dangers of electronic cigarettes are considerably much lower than those of tobacco, since their vapor contains no CO, no tar, and no fine solid particles;

  • The characteristics of the electronic cigarettes should always be compared to those of the conventional cigarette, and if doubts and debates on the perfect long-term safety of some of its components persist, they must be opposed to the absolute certainty of harmfulness of tobacco;

  • Electronic cigarettes can be recommended to all smokers who want to quit smoking, and can be used in combination with patches or with other smoking cessation therapies, if its use is not sufficient to maintain abstinence. E-cigarettes are less addictive than conventional cigarettes, and thus helps to a rapid or gradual tobacco smoking cessation.

We therefore recommend to our colleagues to actively learn about electronic cigarettes, which are a new public health issue in our common fight against tobacco-related diseases. The report and expert opinion on the e-cigarettes from The French Office for Tobacco Prevention (OFT, May 2013 ) is in this respect a remarkable synthesis :

We recommend that research to improve e-cigarettes and e-liquids continue actively, so as to satisfy a growing number of smokers and effectively assist them in smoking cessation. To this end, we support the position of the French authorities not to make e-cigarettes as a medicine, and so to leave the opportunity for research to all potentially concerned industry, to improve safety and efficacy of these products.

Signatories :

Addiction :

- Dr Eve Gelsi, gastro-entérologie, CHRU de Nice

- Pr Pascal Perney, CHU de Nîmes

Allergology :

- Dr Etienne Bidat, Hôpital Ambroise-Paré

- Dr Pierrick Hordé, Boulogne-Billancourt

Andrology :

- Dr Pierre Desvaux, urologie, sexologie, Hôpital Cochin

Anaesthesia-resuscitation :

- Dr William Murphy, Hôpital européen Georges-Pompidou

Biology :

- Dr Carole Emile, CHI Le Raincy-Montfermeil

Cancerology :

- Dr Thierry Dorval, Institut Curie

- Dr Marc Espié, sénologie, Hôpital Saint-Louis

Cardiology :

- Dr Alain Cornen, Réanimation cardiaque, Hôpital privé Clairval

- Pr Martin Juneau, Institut Cardiologique de Montréal

- Dr Pascal Lim, Hôpital Henri-Mondor

Cardiac and Thoracic Surgery :

- Pr Alain Pavie, Hôpital Pitié-Salpêtrière

Dental Surgery :

- Dr Paul Cattanéo, Paris

- Dr Jean-Philippe Roset, Strasbourg

Digestive and Oncological Surgery :

- Pr Jean-Marc Chevallier, Hôpital européen Georges-Pompidou

- Pr Yves Panis, Hôpital Beaujon

Maxillofacial Surgery :

- Pr Pierre Bouletreau, Centre hospitalier Lyon-Sud

Orthopedic Surgery :

- Pr Thomas Bauer, Hôpital Ambroise-Paré

- Pr Philippe Hardy, Hôpital Amboise-Paré

- Pr Rémy Nizard, Hôpital Lariboisière

Plastic, Reconstructive, and Aesthetic Surgery, Hand Surgery

- Pr Christian Dumontier, CHRU de Nice

Thoracic and Vascular Surgery :

- Pr Emmanuel Martinod, Hôpital Avicenne

Vascular and Endocrine Surgery :

- Pr Eric Allaire, Hôpital Henri-Mondor

- Pr Jean-Pierre Becquemin, Hôpital Henri-Mondor

- Pr Pascal Desgranges, Hôpital Henri-Mondor

Dermatology :

- Dr Philippe Evenou, Paris

Endocrinology and Metabolic Diseases :

- Dr Saïd Bekka, diabétologie, CH de Chartes

- Dr Arnaud Cocaul, nutrition, Hôpital Pitié-Salpêtrière

- Dr Jean-Michel Lecerf, nutrition, Institut Pasteur et CHRU de Lille

Geriatry :

- Pr Claude Jeandel, CHU de Montpellier

Gynaecology :

- Dr Joëlle Bensimhon, Hôpital Cochin

- Dr David Elia, Genesis, Paris

- Pr René Frydman, expert reproduction, hôpital Foch de Suresnes

- Dr Christian Jamin, endocrinologie, Paris

- Dr Michèle Lachowsky, psychosomatique, Paris

- Dr Joseph Monsonego, Eurogyn, Paris

- Dr Michèle Pierobon, Paris

Hepatic Gastric Enterology :

- Dr Charles Hagège, Paris

- Pr Patrick Marcellin, hépatologie, Hôpital Beaujon

General Physicians :

- Dr Michel Brack, Paris

- Dr Luc Buhannic, Laboratoire Doliage, Surennes

- Dr Antoine Chollier, Boulogne-Billancourt

- Dr Franck Gigon, La Varenne Saint-Hilaire

- Dr Catherine de Goursac, Paris

- Dr Didier Jourdan, Vieillevigne

- Dr Michel Murino, CIO kantarhealth, Paris

- Dr Alain Rivière, Monfort-en-Chalosse

- Dr Nathalie Szapiro-Manoukian, Trévoux-Tréguignec

Physical Medicine and Re-adaptation :

- Dr Marie-Sandrine Mann-Batard, UGECAM Clémenceau, Strasbourg

Sport Medicine :

- Dr Daniel Gloaguen, Tregunc

- Dr Roland Krzentowsky, rééducation et réadaptation fonctionnelle, Paris

Vascular Medicine :

- Dr Philippe Blanchemaison, Paris

- Dr Christian Gardon-Mollard, Chamalières

- Dr Jean-Pierre Laroche, CHU de Montpellier

- Dr Gilles Miserey, Rambouillet

Neurology :

- Pr Hugues Chabriat, Hôpital de Lariboisière

- Pr Jean-Louis Mas, Hôpital Sainte-Anne

- Dr Caroline Papeix, Hôpital Pitié-Salpêtrière

- Dr Didier Rougemont, Paris

- Pr Emmanuel Touzé, CHU de Caen

Ophthalmology :

- Dr Salomon-Yves Cohen, Hôpital de Lariboisière

- Dr Sandrine Galleri, Istres

- Dr Jean-Paul Lumbroso, Chirurgie réfractive, Paris

- Pr Eric Souïed, Centre hospitalier intercommunal de Créteil

- Dr Xavier Subirana, Paris

- Dr Ronan Tanguy, Lyon

Ears Nose and Throat :

- Dr Michel Hanau, chirurgie cervico-faciale, cancérologie, Groupe Santé Victor Pauchet, Amiens

- Dr Jean-Michel Klein, Président du syndicat national des ORL

- Dr Patrick Sachot, chirurgie cervico-faciale, Clermont-l'Hérault

- Dr Robert Vincent, Chirurgie cervico-faciale, cophochirurgie, Clinique du Dr Jean Causse, Colombiers

Pharmacy :

- Dr Françoise Murjas, Marseille

Exercise Physiology :

- Dr Thibaut Guiraud, Clinique Saint-Orens, Toulouse

Chest Physicians :

- Dr Catherine Daniel, cancérologie, Institut Curie

- Dr Alain Livartowski, cancérologie, Institut Curie

- Dr Gérard Mathern, tabacologie, Saint-Chamond

- Pr Charles-Hugo Marquette, cancérologie, soins intensifs respiratoires, CHRU de Nice

- Dr Hervé Pegliasco, cancérologie, allergologie, Hôpital européen de Marseille

- Dr Jean-Baptiste Stern, Institut Mutualiste Montsouris

Psychiatry :

- Dr Paul Bensussan, expert agréé à la cours de cassation, Versailles

- Dr Nicolas Duchesne, Montpellier

- Dr Yann Hodé, Centre hospitalier de Rouffach

- Dr Pascal Josse, CSAPA et CHU de Nancy

- Pr Christophe Lançon, addictologie, Hôpitaux-Sud Marseille

- Dr Hervé Montes, Orléans

Radiology :

- Dr Thierry Buhé, Saint-Brieuc

- Dr Francis Tobolsky, Paris

Rheumatology :

- Pr Maxime Breban, Hôpital Ambroise-Paré

Public Health :

- Dr Edouard Bidou, Paris

- Pr Jean-François Etter, Institut de médecine sociale et préventive de Genève

- Pr Antoine Flahault, Université Paris Descartes

Sexology :

- Dr Pascal de Sutter, Université de Louvain

Tobaccology (smoking cessation) :

- Dr Gilbert Lagrue, pionnier de la tabacologie à Henri-Mondor

- Dr Béatrice Le Maître, CHU de Caen

- Dr Jacques Le Houezec, Rennes

- Dr Philippe Presles, Institut Moncey

Trauma Emergency :

- Dr Françoise Benhamou, Hôpital Ambroise-Paré

Urology :

- Pr François Haab, Hôpital Tenon

- Pr Gilles Karsenty, Hôpital de la Conception, Marseille

- Pr Arnaud Méjean, Hôpital européen Georges-Pompidou

- Pr Alexandre de la Taille, Hôpital Henri-Mondor

- Pr Olivier Traxer, Hôpital Tenon

Voir les commentaires